1. Home
  2. DSY vs QTTB Comparison

DSY vs QTTB Comparison

Compare DSY & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.27

Market Cap

29.1M

Sector

N/A

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$3.19

Market Cap

25.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
QTTB
Founded
2020
2015
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
25.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSY
QTTB
Price
$0.27
$3.19
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$7.33
AVG Volume (30 Days)
148.5K
9.1M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
N/A
Revenue
$7,323,356.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.85
N/A
Revenue Growth
16.37
N/A
52 Week Low
$0.24
$1.35
52 Week High
$7.33
$6.37

Technical Indicators

Market Signals
Indicator
DSY
QTTB
Relative Strength Index (RSI) 24.59 57.40
Support Level $0.27 $2.92
Resistance Level $0.34 $3.96
Average True Range (ATR) 0.03 0.26
MACD 0.01 -0.01
Stochastic Oscillator 33.12 70.14

Price Performance

Historical Comparison
DSY
QTTB

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: